These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. A booster with SARS-CoV-2 vaccines: protection against Omicron infection. Hu Y; Sun Q Signal Transduct Target Ther; 2022 Apr; 7(1):115. PubMed ID: 35383164 [No Abstract] [Full Text] [Related]
48. T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies. Marasco V; Carniti C; Guidetti A; Farina L; Magni M; Miceli R; Calabretta L; Verderio P; Ljevar S; Serpenti F; Morelli D; Apolone G; Ippolito G; Agrati C; Corradini P Br J Haematol; 2022 Feb; 196(3):548-558. PubMed ID: 34649298 [TBL] [Abstract][Full Text] [Related]
49. COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety. Javadinia SA; Alizadeh K; Mojadadi MS; Nikbakht F; Dashti F; Joudi M; Harati H; Welsh JS; Farahmand SA; Attarian F Front Endocrinol (Lausanne); 2022; 13():860238. PubMed ID: 35586627 [TBL] [Abstract][Full Text] [Related]
50. Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications. Levit E; Longbrake EE; Stoll SS Mult Scler Relat Disord; 2022 Apr; 60():103719. PubMed ID: 35276450 [TBL] [Abstract][Full Text] [Related]
51. Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies. Maglione A; Morra M; Meroni R; Matta M; Clerico M; Rolla S Mult Scler Relat Disord; 2022 May; 61():103776. PubMed ID: 35364386 [TBL] [Abstract][Full Text] [Related]
52. Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination. Inaba T; Okumura K; Maekura C; Muramatsu A; Kobayashi T; Kuroda J; Nukui Y Int J Hematol; 2022 Jun; 115(6):913-914. PubMed ID: 35412265 [No Abstract] [Full Text] [Related]
54. Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma. Bird S; Panopoulou A; Shea RL; Tsui M; Saso R; Sud A; West S; Smith K; Barwood J; Kaczmarek E; Panlaqui C; Kaiser M; Stern S; Pawlyn C; Boyd K Lancet Haematol; 2021 Jun; 8(6):e389-e392. PubMed ID: 33887255 [No Abstract] [Full Text] [Related]
55. Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease. Tees MT; Flinn IW Expert Rev Hematol; 2017 Feb; 10(2):137-146. PubMed ID: 27936980 [TBL] [Abstract][Full Text] [Related]
56. The DiaCoVAb Study in South Italy: Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients. Fucci A; Giacobbe S; Guerriero I; Suzumoto Y; D'Andrea EL; Scrima M; Nolli ML; Iervolino A; Chiuchiolo LA; Salvatore E; Renzulli R; La Peccerella L; Marra G; Liuzzi M; Santoro D; Zulli E; Gentile R; Clemente G; Capasso G Kidney Blood Press Res; 2022; 47(7):467-474. PubMed ID: 35318291 [TBL] [Abstract][Full Text] [Related]
57. [COVID-19 Vaccines for Patients with Neurological Diseases]. Nakajima H Brain Nerve; 2022 Jul; 74(7):893-898. PubMed ID: 35860937 [TBL] [Abstract][Full Text] [Related]
58. Composite Lymphoma as Co-occurrence of Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Carrying Trisomy 12 and t(14;18) and Peripheral T-cell Lymphoma. Aoyama Y; Kodaka T; Zushi Y; Goto Y; Tsunemine H; Itoh T; Takahashi T J Clin Exp Hematop; 2018 Mar; 58(1):27-31. PubMed ID: 29415977 [TBL] [Abstract][Full Text] [Related]
59. Humoral response to SARS-CoV-2 infection and vaccines against COVID-19 in patients with neuromyelitis optica spectrum disorders: Impact of immunosuppressive treatment. Jovicevic V; Ivanovic J; Momcilovic N; Andabaka M; Tamas O; Veselinovic N; Cujic D; Gnjatovic M; Mesaros S; Pekmezovic T; Drulovic J Mult Scler Relat Disord; 2022 Jun; 62():103794. PubMed ID: 35421782 [TBL] [Abstract][Full Text] [Related]
60. B Cell Numbers Predict Humoral and Cellular Response Upon SARS-CoV-2 Vaccination Among Patients Treated With Rituximab. Stefanski AL; Rincon-Arevalo H; Schrezenmeier E; Karberg K; Szelinski F; Ritter J; Jahrsdörfer B; Schrezenmeier H; Ludwig C; Sattler A; Kotsch K; Chen Y; Claußnitzer A; Haibel H; Proft F; Guerra G; Durek P; Heinrich F; Ferreira-Gomes M; Burmester GR; Radbruch A; Mashreghi MF; Lino AC; Dörner T Arthritis Rheumatol; 2022 Jun; 74(6):934-947. PubMed ID: 34962360 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]